Notably, the same meta-analysis highlighted that liraglutide, particularly when compared to higher doses of semaglutide or tirzepatide, promoted weight loss without a clinically meaningful reduction in lean mass [77]
If the FDA will require outcomes trials for future approvals in obesity, this will add considerable time and cost to drug development
As such, GLP-1 has become the parent compound for the development of GLP-1RAs
Gln is transported to cells where it acts as a starting material for the production of different amino acids, proteins, nucleotides, and other important biological molecules
For IHD, individual feature categoriesexcept for serum metabolomics (EV 19.5%)performed poorly, with the full model accounting for 16.1% of circulating TMAO variance (Supplementary Fig
Looking ahead, the remaining states may be reluctant to add a new, expensive drug benefit while they brace for potential federal cuts coming from Congress, she said